CLDX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Celldex Therapeutics (CLDX) Earnings Date & Reports

Celldex Therapeutics Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CLDX is expected to report earnings to rise 6.59% to -75 cents per share on May 01

Celldex Therapeutics CLDX Stock Earnings Reports

Q1'25

Est.

$-0.76

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.15

The last earnings report on February 27 showed earnings per share of -70 cents, missing the estimate of -68 cents. With 452.68K shares outstanding, the current market capitalization sits at 1.30B.

View a ticker or compare two or three

Compare

CLDX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CLDX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CLDX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of immunotherapy technologies for the treatment of cancer and other diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

53 Frontage Road

Phone

+1 908 200-7500

Employees

160

Web

https://www.celldex.com